Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1601-9. doi: 10.1016/j.msec.2012.04.050. Epub 2012 Apr 28.
In this paper the authors present a simple method of coating polyurethane (PU) surface with poly(vinyl pirrolidone) (PVP) hydrogel. The hydrogel-coated materials were designed for use in biomedical applications, especially in blood-contacting devices. The coating is formed due to free radical macromolecular grafting-crosslinking. Polymer surface was first immersed in an organic solution containing radical source: cumene hydroperoxide (CHP) with an addition of a branching and anchoring agent: ethylene glycol dimethylacrylate (EGDMA). In the second step, the substrate was immersed in a water solution containing given concentration of PVP and Fe(2+). The novelty of the process consists in the fact that free radicals are formed mostly at the polymer/solution interface, what assures high grafting efficiency together with the formation of covalent bonds between polymer substrate and modifying layer. The process was optimized for reagents concentrations. The coating properties: thickness and the swelling ratio were strongly influenced by CHP, Fe(2+), PVP and EGMDA concentrations. The chemical composition of the surface analyzed with FTIR-ATR spectroscopy confirmed the presence of PVP coating. In vitro biocompatibility tests with L929 fibroblasts confirmed non-cytotoxicity of the coatings. Hydrogel coating significantly improved polyurethane hemocompatibility. Studies with human whole blood revealed that both, the platelet consumption and the level of platelet activation were as low as for negative control.
本文作者提出了一种在聚氨酯(PU)表面涂覆聚(乙烯基吡咯烷酮)(PVP)水凝胶的简单方法。设计这种水凝胶涂层材料用于生物医学应用,特别是在与血液接触的设备中。该涂层是通过自由基高分子接枝交联形成的。首先将聚合物表面浸入含有自由基源:过氧化枯烯(CHP)和支化剂和锚固剂:二乙二醇二甲基丙烯酸酯(EGDMA)的有机溶液中。第二步,将基底浸入含有特定浓度 PVP 和 Fe(2+)的水溶液中。该过程的新颖之处在于自由基主要在聚合物/溶液界面形成,这确保了高接枝效率以及聚合物基底和改性层之间形成共价键。该过程的优化是针对试剂浓度进行的。涂层的性能:厚度和溶胀比强烈受 CHP、Fe(2+)、PVP 和 EGMDA 浓度的影响。用傅里叶变换衰减全反射光谱法(FTIR-ATR)分析的表面化学组成证实了 PVP 涂层的存在。用 L929 成纤维细胞进行的体外生物相容性测试证实了涂层无细胞毒性。水凝胶涂层显著改善了聚氨酯的血液相容性。对人全血的研究表明,血小板消耗和血小板激活水平与阴性对照一样低。